- Home
- CSTL vs THR Comparison
CSTL vs THR Comparison
Compare CSTL & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CSTL | THR |
|---|---|---|
| Founded | 2007 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CSTL | THR |
|---|---|---|
| Price | $40.31 | $41.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $46.00 | N/A |
| AVG Volume (30 Days) | ★ 331.6K | 199.6K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.04 |
| EPS | N/A | ★ 1.75 |
| Revenue | $343,530,000.00 | ★ $509,054,000.00 |
| Revenue This Year | $2.54 | $4.87 |
| Revenue Next Year | N/A | $4.78 |
| P/E Ratio | ★ N/A | $23.40 |
| Revenue Growth | ★ 10.15 | 3.08 |
| 52 Week Low | $14.59 | $23.05 |
| 52 Week High | $42.18 | $41.92 |
Technical Indicators
Market Signals| Indicator | CSTL | THR |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 67.84 |
| Support Level | $38.73 | $40.15 |
| Resistance Level | $41.60 | $41.92 |
| Average True Range (ATR) | 1.58 | 1.07 |
| MACD | -0.12 | 0.18 |
| Stochastic Oscillator | 62.75 | 83.27 |
Price Performance
Historical ComparisonAbout CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.